The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Some stimulatory receptors of the innate immune system, such as the NKG2D receptor (also called KLRK1) expressed by natural killer cells and activated CD8(+)T cells, recognize self-molecules that are upregulated in diseased cells by poorly understood mechanisms. Here we show that mouse and human NKG2D ligands are upregulated in non-tumour cell lines by genotoxic stress and stalled DNA replication, conditions known to activate a major DNA damage checkpoint pathway initiated by ATM (ataxia telangiectasia, mutated) or ATR (ATM- and Rad3-related) protein kinases. Ligand upregulation was prevented by pharmacological or genetic inhibition of ATR, ATM or Chk1 (a downstream transducer kinase in the pathway). Furthermore, constitutive ligand expression by a tumour cell line was inhibited by targeting short interfering RNA to ATM, suggesting that ligand expression in established tumour cells, which often harbour genomic irregularities, may be due to chronic activation of the DNA damage response pathway. Thus, the DNA damage response, previously shown to arrest the cell cycle and enhance DNA repair functions, or to trigger apoptosis, may also participate in alerting the immune system to the presence of potentially dangerous cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, genomic damage—a common cause of cellular senescence—induces expression of the membrane-bound ligands for the major natural killer cell receptor NKG2D (140).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [140]
The cited source says what the claim attributes to it.
In the citing paper
“other evidence indicates that the immune system's recognition of tumour cells might require the continuous activation of the DDR pathway 13”
From The common biology of cancer and ageing (2007) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Further, DNA damage or activation of oncogenes can induce cellular senescence, through a pathway that relies, in part, on the secretion of pro-inflammatory cytokines such as insulin-like growth factor binding protein-7 (IGFBP7)32 and IL-633, and on the secretion of CXC-chemokine ligand 8 (CXCL8) and other chemokines 33,34, as well as on the expression of the CXCL8 receptor CXC-chemokine receptor 2”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredIn the citing paper
“These findings are consistent with previous studies suggesting that NKG2D ligands are induced by a variety of other stimuli, including E2F transcription factors, PI3 kinase, Ras oncogene signaling, and an activated DNA damage response (Gasser et al., 2005; Tokuyama et al., 2011; Jung et al., 2012).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Gasser et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: p73α Regulation by Chk1 in Response to DNA Damage
Gonzalez, S., Prives, C., & Cordon-Cardo, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8161-8171.2003 · Cited by 75
RetractedDNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Self-citation(1999) · PubMed · Cited by 1,030
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
Self-citation
Cited by
Items 401–500 of 1,000
Kohga, K., Takehara, T., Tatsumi, T., Ohkawa, K., Miyagi, T., Hiramatsu, N., Kanto, T., Kasugai, T., Katayama, K., Kato, M., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00859.x · Cited by 73
Croxford, J. L., Tang, M. L. F., Pan, M. F., Huang, C. W., Kamran, N., Phua, C., Chng, W. J., Ng, S., Raulet, D. H., & Gasser, S. (2013) · Blood · doi:10.1182/blood-2012-08-449025 · Cited by 72
Self-citationMolecular Bases for the Regulation of NKG2D Ligands in Cancer
Huergo-Zapico, L., Acebes‐Huerta, A., López‐Soto, A., Villa-Ãlvarez, M. N., González, A. P., & Gonzalez, S. R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00106 · Cited by 80
“DNA damage response Non-tumor cell lines Mouse and human ligands (30)”
BackgroundInfluentialYoon, M. S., Pham, T. C., Phan, M. T., Shin, D., Jang, Y.-Y., Park, M., Kim, S., Kim, S., & Cho, D. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.08.006 · Cited by 75
der Most, R. G. V., Currie, A. J., Robinson, B. W. S., & Lake, R. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402255 · Cited by 79
“DNA damage causes cells to upregulate their expression of the ligands for NKG2D.(55,56)”
Backgroundon behalf of the Cancer Immunotherapy Trials Network (CITN), Kohrt, H. E. K., Tumeh, P. C., Benson, D., Bhardwaj, N., Brody, J., Formenti, S. C., Fox, B. A., Galon, J., June, C. H., et al. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0118-0 · Cited by 75
“Therefore, sMICA may be the first biomarker of combination radiation and immunotherapy [34], and as radiation therapy upregulates MICA on the surface of tumor cells, serial biopsies of tumors before and after radiation therapy and ipilimumab are required to assess this immunodynamic endpoint with increased expression…”
BackgroundInfluentialTextor, S., Dürst, M., Jansen, L., Accardi, R., Tommasino, M., Trunk, M., Porgador, A., Watzl, C., Gissmann, L., & Cerwenka, A. (2008) · International Journal of Cancer · doi:10.1002/ijc.23733 · Cited by 82
Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression
Jones, A. B., Rocco, A., Lamb, L. S., Friedman, G. K., & Hjelmeland, A. B. (2022) · Cancers · doi:10.3390/cancers14092339 · Cited by 73
Okita, R., Mougiakakos, D., Ando, T., Mao, Y., Sarhan, D., Wennerberg, E., Seliger, B., Lundqvist, A., Mimura, K., & Kiessling, R. W. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102237 · Cited by 73
“inhibitors of DNA replication, can induce NKG2DLs (5).”
BackgroundInfluentialBae, J.-H., Kim, J.-Y., Kim, M.-J., Chang, S.-H., Park, Y.-S., Son, C.-H., Park, S.-J., Chung, J.-S., Lee, E.-Y., Kim, S.-H., et al. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181d32f22 · Cited by 68
Berghuis, D., Schilham, M. W., Vos, H. I., Santos, S. J., Kloeß, S., Buddingh, E. P., Egeler, R. M., Hogendoorn, P. C. W., & Lankester, A. C. (2012) · Clinical Sarcoma Research · doi:10.1186/2045-3329-2-8 · Cited by 70
“In addition to a direct epigenetic effect resulting in increased expression of target genes, HDI may induce activation of the ATM/ATR-mediated DNA damage response which, in turn, induces NKG2D ligand expression [16].”
BackgroundNF-κB signaling as a driver of ageing
Osorio, F. G., Soria‐Valles, C., Santiago‐Fernández, O., Freije, J. M. P., & López-Otín, C. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.04.003 · Cited by 75
Engineered natural killer cells for cancer therapy
Biederstädt, A., & Rezvani, K. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.09.013 · Cited by 69
Cerboni, C., Ardolino, M., Santoni, A., & Zingoni, A. (2009) · Blood · doi:10.1182/blood-2008-06-165944 · Cited by 70
Rodríguez‐Rodero, S., Gonzalez, S. R., Rodrigo, L., Fernández-Morera, J. L., Martínez-Borra, J., López‐Vázquez, A., & López‐Larrea, C. (2007) · European Journal of Immunology · doi:10.1002/eji.200737031 · Cited by 75
Fionda, C., Abruzzese, M. P., Zingoni, A., Soriani, A., Ricci, B., Molfetta, R., Paolini, R., Santoni, A., & Cippitelli, M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1023-5 · Cited by 70
“Moreover, we identified one of the possible mechanism(s) involved in this up-regulation, the activation of a DNA damage response, a molecular pathway already described to regulate the expression of NK cells activating ligands in several cellular models [12,24,64].”
BackgroundThe Role of MicroRNAs in the Control of Innate Immune Response in Cancer
Jasinski-Bergner, S., Mandelboim, O., & Seliger, B. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju257 · Cited by 63
“Other cellular pathways activated during viral infection or malignant transformation like signalling via the toll-like receptors (TLR)-4 and TLR-7/8 or cytokine receptors could also induce a differentiall transcription of NKG2D-L: IFN-γ and TGF-β downregulate MICA and ULBP expression in melanoma and glioblastoma cells…”
BackgroundMutanome directed cancer immunotherapy
Vormehr, M., Diken, M., Boegel, S., Kreiter, S., Türeci, Ÿ., & Şahin, U. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.12.001 · Cited by 70
“An alternative or complementary explanation is that a higher mutational load may be associated with an increased activation of DNA damage pathways activating apoptosis and ultimately stimulating innate immune mechanisms which in turn promote the induction of immune responses [51].”
Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells
Antonangeli, F., Soriani, A., Ricci, B., Ponzetta, A., Benigni, G., Morrone, S., Bernardini, G., & Santoni, A. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1218105 · Cited by 64
“p53-independent, whereas involving E2F1 transcription factor.(41,58,59)”
The emerging role of γδ T cells in cancer immunotherapy
Nussbaumer, O., & Koslowski, M. (2019) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2019.06.002 · Cited by 70
“This stress signal can be induced via the DNA repair response after ultraviolet exposure [21], oncogenes such as Ras [22], osmotic shock and/or oxidative stress via epidermal growth factor receptor signalling [23].”
BackgroundMechanisms of Resistance to NK Cell Immunotherapy
Sordo‐Bahamonde, C., Vitale, M., Lorenzo‐Herrero, S., López‐Soto, A., & Gonzalez, S. R. (2020) · Cancers · doi:10.3390/cancers12040893 · Cited by 71
“Thus, DNA damage, oxidative stress or proliferative stress signaling pathways induce the expression of NKG2D ligands, initiating an immune response against the target cells [10,13,14].”
BackgroundCotter, S. E., Dunn, G. P., Collins, K. M., Sahni, D., Zukotynski, K., Hansen, J. L., O’Farrell, D. A., Ng, A. K., Devlin, P. M., & Wang, L. C. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.176 · Cited by 66
Conceptual aspects of self and nonself discrimination
Gonzalez, S. R., González, A. P., López‐Soto, A., Huergo-Zapico, L., López‐Larrea, C., & Suárez-Álvarez, B. (2011) · Self/Nonself · doi:10.4161/self.2.1.15094 · Cited by 78
“However, one of the surprises of tumor immunology was the finding that much of the adaptive immune response to tumor cells was directed against non mutated self antigens rather than against mutated self proteins that differentiated them from normal sequence.(6,28,36) Indeed, some of the tumor antigens turned out to be…”
BackgroundInduction of MHC class I-related chain B (MICB) by 5-aza-2′-deoxycytidine
Tang, K., He, C., Zeng, G.-L., Wu, J., Song, G., Shi, Y., Zhang, W., Huang, A., Steinle, A., & Ren, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.131 · Cited by 72
Okita, R., Yukawa, T., Nojima, Y., Maeda, A., Saisho, S., Shimizu, K., & Nakata, M. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1814-9 · Cited by 66
“MICA/B expression is regulated by the DNA damage-induced ATM–ATR pathway [22] and the oncogene-induced PI3K–AKT signaling pathway [19, 21].”
BackgroundRationale for stimulator of interferon genes–targeted cancer immunotherapy
Rivera Vargas, T., Benoit-Lizon, I., & Apetoh, L. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2016.12.028 · Cited by 65
Raulet, D. H., Marcus, A., & Coscoy, L. (2017) · Immunological Reviews · doi:10.1111/imr.12600 · Cited by 65
Self-citationNatural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review
Uppendahl, L. D., Dahl, C. M., Miller, J. S., Felices, M., & Geller, M. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01825 · Cited by 72
Chisholm, S. E., Howard, K., Valés‐Gómez, M., & Reyburn, H. T. (2007) · The Journal of Infectious Diseases · doi:10.1086/512862 · Cited by 76
“sociated with expression of ligands for the NKG2D receptor [40].”
BackgroundMethodAppleton, E. S., Hassan, J., Hak, C. C. W., Sivamanoharan, N., Wilkins, A. C., Samson, A., Lab), M. O. (., Harrington, K. J., Melcher, A. A., & Wennerberg, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.754436 · Cited by 68
“Death-receptor upregulation Augmented NK cell and CD8 T cell cytotoxicity (32, 33)”
BackgroundSenescent T cells: Beneficial and detrimental roles
Laphanuwat, P., Gomes, D. C. O., & Akbar, A. N. (2023) · Immunological Reviews · doi:10.1111/imr.13206 · Cited by 67
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
Tan, G., Spillane, K. M., & Maher, J. F. (2023) · Biology · doi:10.3390/biology12081079 · Cited by 79
Evasion from NK cell-mediated immune responses by HIV-1
Jost, S., & Altfeld, M. A. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.05.001 · Cited by 66
“Indeed, it is known that DNA damage leads to the up-regulation of NKG2D ligands [99].”
Zhang, T., & Sentman, C. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3200 · Cited by 65
The confluence of radiotherapy and immunotherapy
Burnette, B., Fu, Y., & Weichselbaum, R. R. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00143 · Cited by 68
Lee, H.-R., Son, C., Koh, E.-K., Bae, J.-H., Kang, C., Yang, K., & Park, Y.-S. (2017) · Scientific Reports · doi:10.1038/s41598-017-09259-1 · Cited by 70
Shi, P., Yin, T., Zhou, F., Cui, P., Gou, S., & Wang, C. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-370 · Cited by 68
“In response to DNA damage, the expression of MICA and MICB can be induced by ATM and ATR, which are components of DNA damage signaling pathways [24,29,30]; these effects can be prevented by ATM/ATR inhibitors.”
BackgroundDendritic Cell Interactions with NK Cells from Different Tissues
Ferlazzo, G., & Münz, C. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9283-y · Cited by 68
“, tumor and infected cells or proliferating cells), for which genomic instability might be one hallmark [19].”
BackgroundPost-transplantation malignancies: here today, gone tomorrow?
Geissler, E. K. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.186 · Cited by 75
DNA Damage: From Chronic Inflammation to Age-Related Deterioration
Ιωαννίδου, Ά., Goulielmaki, E., & Garinis, G. A. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00187 · Cited by 71
Hosomi, S., Grootjans, J., Tschurtschenthaler, M., Krupka, N., Matute, J. D., Flak, M. B., Martinez-Naves, E., Gomez del Moral, M., Glickman, J. N., Ohira, M., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162041 · Cited by 62
EGFR inhibitors enhanced the susceptibility to NK cell-mediated lysis of lung cancer cells
Kim, H., Kim, S.-H., Kim, M.-J., Kim, S.-J., Park, S.-J., Chung, J.-S., Bae, J.-H., & Kang, C.-D. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31821b724a · Cited by 63
Cunha, L. L., Ferreira, R. C. U., Marcello, M. A., Vassallo, J., & Ward, L. S. (2011) · Journal of Thyroid Research · doi:10.4061/2011/387062 · Cited by 63
“These are expressed by natural killer cells and activated CD8+ T cells of the innate immune system [139].”
BackgroundModulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activation
Leung, W., Vong, Q. P., Lin, W., Janke, L. J., Chen, T., & Leung, W. H. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20122292 · Cited by 67
Advances in NKG2D ligand recognition and responses by NK cells
Bert, N. L., & Gasser, S. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2013.111 · Cited by 64
Self-citationVantourout, P., Willcox, C. R., Turner, A., Swanson, C. M., Haque, Y., Sobolev, O., Grigoriadis, A. E., Tutt, A. N. J., & Hayday, A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007579 · Cited by 68
“The common association of NKG2D ligand expression with cancer cells is consistent with evidence that murine Rae1 is upregulated in response to DNA damage (12).”
BackgroundRas Activation Induces Expression of Raet1 Family NK Receptor Ligands
Liu, X. V., Ho, S. S. W., Tan, J. J., Kamran, N., & Gasser, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200965 · Cited by 60
“We and others have demonstrated that NKG2D ligand expression can be induced by DNA damage and oxidative stress (7, 8).”
BackgroundSelf-citationRamirez‐Garcés, D., Camborde, L., Pel, M. J. C., Jauneau, A., Martinez, Y., Néant, I., Leclerc, C., Moreau, M., Dumas, B., & Gaulin, E. (2015) · New Phytologist · doi:10.1111/nph.13774 · Cited by 66
Cancer immunotherapy: how low-level ionizing radiation can play a key role
Janiak, M. K., Wincenciak, M., Cheda, A., Nowosielska, E. M., & Calabrese, E. J. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-1993-z · Cited by 68
Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti- versus Pro-Tumoral Activities
Xiang, Z., & Tu, W. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01041 · Cited by 65
“Together with previous studies, we reported that NKG2D can bind to its ligands (71), such as MICA, MICB, and ULBP-1, -2, -3, and -4, which are expressed in different tumors, including leukemia, lymphoma, ovarian, and colon carcinoma (72–74).”
BackgroundHede, D. V., Polese, B., Humblet, C., Wilharm, A., Renoux, V., Dortu, E., de Leval, L., Delvenne, P., Desmet, C. J., Bureau, F., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712883114 · Cited by 69
“For example, high-risk HPV E7 has been shown to activate the ATM DNA damage response in keratinocytes (26), a pathway that is implicated in the up-regulation of NKG2D ligands (27).”
BackgroundInterferon α in cancer immunoediting: From elimination to escape
Vidal, P. D. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12863 · Cited by 69
Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibility
Cipolat, S., Hoste, E., Natsuga, K., Quist, S. R., & Watt, F. M. (2014) · eLife · doi:10.7554/elife.01888 · Cited by 62
“Tissue damage triggers upregulation of keratinocyte ‘stress-associated’ genes such as Rae-1 (Gasser et al., 2005) and H60 (Whang et al., 2009).”
BackgroundBöll, B., Eltaib, F. I., Reiners, K. S., von Tresckow, B., Tawadros, S., Simhadri, V. R., Burrows, F. J., Lundgren, K., Hansen, H. P., Engert, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0213 · Cited by 67
Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease
Davies, J. O. J., Stringaris, K., Barrett, A. J., & Rezvani, K. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.03.009 · Cited by 65
“Ligands of the NKG2D receptor may be upregulated as part of the DNA damage response induced by chemotherapy and radiotherapy, and it is likely that NK cells play a key role in mediating tumor cell apoptosis after these cytotoxic treatments [115].”
BackgroundThe Role of NK Cells and Innate Lymphoid Cells in Brain Cancer
Sedgwick, A. J., Ghazanfari, N., Constantinescu, P., Mantamadiotis, T., & Barrow, A. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01549 · Cited by 68
Faye, M. D., Kassouf, W., Souhami, L., Marcq, G., Cury, F., Niazi, T. M., & Sargos, P. (2020) · World Journal of Urology · doi:10.1007/s00345-020-03440-4 · Cited by 64
Immune Surveillance of Unhealthy Cells by Natural Killer Cells
Iannello, A., & Raulet, D. H. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020255 · Cited by 54
“that constitutively express those ligands (Gasser et al. 2005).”
InfluentialSelf-citationSegovis, C. M., Schoon, R. A., Dick, C. J., Nacusi, L. P., Leibson, P. J., & Billadeau, D. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803840 · Cited by 61
Westbrook, A. M., & Schiestl, R. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2584 · Cited by 59
“Genotoxic insult and activation of the ATM/ATR pathway were shown to upregulate ligands for the NKG2D receptor in mice and in humans, present on all NK cells, γδ-T cells, and activated CD8 T cells (46).”
BackgroundMechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell–Treated Mice
Sentman, M.-L., Murad, J. M., Cook, W. J., Wu, M.-R., Reder, J., Baumeister, S. H., Dranoff, G., Fanger, M. W., & Sentman, C. L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600769 · Cited by 61
Tremblay-McLean, A., Coenraads, S., Kiani, Z., Dupuy, F. P., & Bernard, N. F. (2019) · BMC Immunology · doi:10.1186/s12865-018-0272-x · Cited by 67
Immunomodulation of NK Cells by Ionizing Radiation
Chen, J., Liu, X., Zeng, Z., Li, J., Luo, Y. M., Sun, W., Gong, Y. Q., Zhang, J., Wu, Q., & Xie, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00874 · Cited by 65
“In vitro, IR significantly upregulated NKG2D ligands in a time-dependent manner, rendering malignant cells more sensitive to NK cells (28, 85), which was probably ascribed to the DNA damage response pathway (86).”
BackgroundRegulation of NKG2D Expression and Signaling by Endocytosis
Molfetta, R., Quatrini, L., Zitti, B., Capuano, C., Galandrini, R., Santoni, A., & Paolini, R. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.015 · Cited by 64
“In cancer cells, the first link between DDR and upregulation of NKG2D ligand expression was provided by Gasser and coworkers: they demonstrated that genotoxic stress conditions are [10_TD$DIFF]responsible for persistent NKG2D ligand expression mainly through ATM, ATR, and Chk1 activation [3_TD$DIFF],[11_TD$DIFF] thus…”
BackgroundImpact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks
Isernhagen, A., Malzahn, D., Bickeböller, H., & Dressel, R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00588 · Cited by 64
“MICA is constitutively expressed only on a few cell types, including gastrointestinal epithelium, but is induced due to cellular and genotoxic stress (3, 4), malignant transformation, or virus infection”
Why did the acquired immune system of vertebrates evolve?
Rolff, J. (2006) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2006.08.009 · Cited by 63
“T cells with direct antigen recognition such as gdT cells play an important role in cancer surveillance: gdT are able to recognise NKG2D ligands and to kill carcinoma cells [35,36].”
BackgroundTargeting the NKG2D/NKG2D-L axis in acute myeloid leukemia
Wu, Z., Zhang, H., Wu, M., Peng, G., He, Y., Wan, N., & Zeng, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111299 · Cited by 59
Alseksek, R. K., Ramadan, W. S. H., Saleh, E., & El‐Awady, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158141 · Cited by 66
Densely Granulated Murine NK Cells Eradicate Large Solid Tumors
Liu, R. B., Engels, B., Arina, A., Schreiber, K., Hyjek, E., Schietinger, A., Binder, D. C., Butz, E., Krausz, T., Rowley, D. A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3208 · Cited by 54
“for activating receptors on NK cells (7, 8), and thus are targets of NK cells and their receptors.”
Nice, T. J., Deng, W., Coscoy, L., & Raulet, D. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000247 · Cited by 59
“Stress pathways, most notably the DNA damage and heat-shock pathways, were shown to induce ligand expression on cell lines in vitro (5, 6).”
BackgroundSelf-citationSantoni, A., Zingoni, A., Cerboni, C., & Gismondi, A. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2007.00513.x · Cited by 68
Patel, M. A., Kim, J. E., Theodros, D., Tam, A. J., Velarde, E., Kochel, C. M., Francica, B. J., Nirschl, T. R., Ghasemzadeh, A., Mathios, D., et al. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0132-2 · Cited by 59
“One hypothesis is that the damage of tumor cells produces an immunogenic substrate for infiltrating effector lymphocytes through the release of antigens as well as upregulation of cytokines and pro-inflammatory ligands [31–35].”
BackgroundDNA Damage Response and Metabolic Reprogramming in Health and Disease
Chatzidoukaki, O., Goulielmaki, E., Schumacher, B., & Garinis, G. A. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.06.018 · Cited by 62
NK Cell Receptors as Tools in Cancer Immunotherapy
Sentman, C. L., Barber, M. A., Barber, A., & Zhang, T. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95007-6 · Cited by 61
“Data suggest that, in many cases, the process of transformation often leads to expression of ligands for NKG2D, and the induction of MICA and MICB expression is dependent upon DNA damage in cells (Gasser et al., 2005).”
Natural Killer Cells: From Basic Research to Treatments
Vivier, É., & Ugolini, S. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00018 · Cited by 58
“In addition to the recognition of microbial molecules by a variety of innate immune receptors, the so-called “infectious non-self recognition,” it has been shown that some receptors of innate immune cells can detect internal changes, leading to the concept of “stressinduced self recognition” (Bauer et al., 1999; Gasse…”
InfluentialDressel, R. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0266-8 · Cited by 66
“Normally, NKG2D ligands are not expressed on healthy cells but they can become induced by conditions, such as heat shock [150], virus infection [151], or genotoxic stress [152].”
BackgroundAnuja, K., Roy, S., Ghosh, C., Gupta, P., Bhattacharjee, S., & Banerjee, B. (2016) · Inflammation Research · doi:10.1007/s00011-016-0985-3 · Cited by 64
Marlin, R., Duriez, M., Berkane, N. B., de Truchis, C., Madec, Y., Rey, M. A., Cummings, J.-S., Cannou, C., Quillay, H., Barré‐Sinoussi, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030017 · Cited by 59
“Moreover, the increase of NKG2D expression may help to protect the fetus against pathogenic infections, since the NKG2D ligands, MICA/B and ULBP1-5, are mainly induced by cellular stresses such as cell damage or pathogen infection [41,42].”
BackgroundTime-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
Alagkiozidis, I., Facciabene, A., Tsiatas, M., Carpenito, C., Benencia, F., Adams, S., Jonak, Z., June, C. H., Powell, D. J., & Coukos, G. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-77 · Cited by 55
“Previous reports have suggested that the exposure of tumor cells to chemotherapeutic drugs can sensitize them to immune effector cells [3-6].”
BackgroundIsernhagen, A., Schilling, D., Monecke, S., Shah, P. N., Elsner, L., Walter, L., Multhoff, G., & Dressel, R. (2015) · Immunogenetics · doi:10.1007/s00251-015-0884-8 · Cited by 57
“…is constitutively expressed on a few cell types, including gastrointestinal epithelium (Groh et al. 1996); however, following cellular or genotoxic stress (Gasser et al. 2005; Groh et al. 1996), it can be induced on malignant or virus-infected cells (Champsaur and Lanier 2010; Raulet et al. 2013).”
BackgroundInfluentialTuning cancer fate: the unremitting role of host immunity
Calì, B., Molon, B., & Viola, A. (2017) · Open Biology · doi:10.1098/rsob.170006 · Cited by 62
Apps, R., Gardner, L., Traherne, J. A., Male, V. H., & Moffett, A. (2008) · Human Reproduction · doi:10.1093/humrep/den223 · Cited by 57
“NKG2DL expression can be induced in other tissues by stresses such as infection or transformation (Groh et al., 2001; Gasser et al., 2005).”
BackgroundInfluentialRegulation of natural killer cell activity
Kirwan, S. E., & Burshtyn, D. N. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.11.012 · Cited by 65
Høgh, R. I., Møller, S. H., Jepsen, S. D., Mellergaard, M., Lund, A., Pejtersen, M., Fitzner, E., Andresen, L., & Skov, S. (2020) · The FASEB Journal · doi:10.1096/fj.202000162r · Cited by 56
Smith, D. W., Chakravorty, A., Hayes, M., Hammerschmidt, W., & Sugden, B. (2021) · mBio · doi:10.1128/mbio.02243-21 · Cited by 58
“activation of the ATR/Chk1 and ATM/Chk2 pathways, which play vital roles connected to DNA damage and replication stress (7, 8).”
BackgroundGut microbiota regulates NKG2D ligand expression on intestinal epithelial cells
Hansen, C. H. F., Holm, T. L., Krych, Ł., Andresen, L. O., Nielsen, D. S., Rune, I., Hansen, A. K., & Skov, S. (2012) · European Journal of Immunology · doi:10.1002/eji.201242462 · Cited by 61
TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors
Maccalli, C., Scaramuzza, S., & Parmiani, G. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0635-x · Cited by 58
“cells; the expression of these ligands in tumor cells harboring genomic aberrations may be due to chronic activation of DNA damage response pathway [23].”
BackgroundFrenzel, L. P., Abdullah, Z., Kriegeskorte, A. K., Dieterich, R., Lange, N., Busch, D. H., Krönke, M., Utermöhlen, O., Hescheler, J., & Šarić, T. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0528 · Cited by 57
The injury response to DNA damage in live tumor cells promotes antitumor immunity
Sriram, G., Milling, L. E., Chen, J.-K., Kong, Y. W., Joughin, B. A., Abraham, W. D., Swartwout, S., Handly, E. D., Irvine, D. J., & Yaffe, M. B. (2021) · Science Signaling · doi:10.1126/scisignal.abc4764 · Cited by 56
“Exactly how the activation of the DNA damage responsive phosphatidylinositol 3-kinase–like kinases ATM, ATR, and DNA-PK, as well as p38 MAPK and NF-B, contributes to the immunogenicity of the live injured cells remains to be clarified in future work but could involve, for example, up-regulation of antigenic determina…”
BackgroundElsner, L., Flügge, P. F., Lozano-Kühne, J., Muppala, V., Eiz‐Vesper, B., Nussbeck, S. Y., Malzahn, D., Herrmann, T., Brunner, E., Bickeböller, H., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00677.x · Cited by 56
“Similar induction patterns have been described also for other cell lines [35].”
BackgroundCapitalizing on the Immunogenicity of Dying Tumor Cells
Fonseca, C., & Dranoff, G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2245 · Cited by 63
Wu, J. D., Atteridge, C. L., Wang, X., Seya, T., & Plymate, S. R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1305 · Cited by 58
The interplay between the immune system and chemotherapy: emerging methods for optimizing therapy
Ghiringhelli, F., & Apétoh, L. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.865520 · Cited by 60
Acebes-Huerta, A., Lorenzo-Herrero, S., Folgueras, A. R., Huergo-Zapico, L., Lopez-Larrea, C., López-Soto, A., & Gonzalez, S. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1074378 · Cited by 51
“Hyperploidy triggers the DNA damage response (DDR), which enhances the expression of NKG2D ligands through the activation of ATM/ATR.(24,35,36) Our experiments show that genetic and pharmacological inhibition of ATM reduces the expression of MICA, clearly indicating that the DDR mediates the induction of NKG2D ligands…”
BackgroundAndresen, L. O., Jensen, H., Pedersen, M. T., Hansen, K. A., & Skov, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8235 · Cited by 55
El-Jawhari, J. J., El-Sherbiny, Y. M., Scott, G. B., Morgan, R. S. M., Prestwich, R., Bowles, P. A., Blair, G. E., Tanaka, T., Rabbitts, T. H., Meade, J. L., et al. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2013.11.020 · Cited by 54
“Oncogenic transformation itself is insufficient to induce NKG2D ligand expression (Gasser et al., 2005).”
BackgroundKuraoka, M., Liao, D., Yang, K., Allgood, S. D., Levesque, M. C., Kelsoe, G. H., & Ueda, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901548 · Cited by 54
Natural killer cells: The journey from puzzles in biology to treatment of cancer
Bodduluru, L. N., Kasala, E. R., Madhana, R. M., & Sriram, C. S. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.020 · Cited by 61
“In addition, the chemotherapeutic agents, such as 5-fluorouracil, Ara-C and cisplatin, radiation as well as antineoplastic drugs such as 5-aza-2′-deoxycytidine, trichostatin A, bryostatin-1 and all transretinoic acid also increase the expression of NKG2DL on tumor cells [22, 79, 80].”
BackgroundGowen, B. G., Chim, B., Marceau, C. D., Greene, T. T., Burr, P., Gonzalez, J. R., Hesser, C. R., Dietzen, P. A., Russell, T. A., Iannello, A., et al. (2015) · eLife · doi:10.7554/elife.08474 · Cited by 58
“Such approaches have implicated the DNA damage response pathway (Gasser et al., 2005), heat shock (Venkataraman et al., 2007; Nice et al., 2009), hyperproliferation (Jung et al., 2012), and pattern recognition receptors (Hamerman et al., 2004), among others, in the regulation of one or more NKG2D…”
BackgroundInfluentialSelf-citationCombination therapy: Future directions of immunotherapy in small cell lung cancer
Huang, W., Chen, J., Xing, R., & Zeng, Y. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100889 · Cited by 58
“For example, cisplatin, the common drug in the treatment of SCLC, can activateNK cells by triggered the expression of ligands of the activating NK cells receptor NKG2D [48].”
Background
Metadata
- Authors
- Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- University of Pennsylvania (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature
- Published
- 2005-07-03
- Volume
- 436
- Issue
- 7054
- Pages
- 1186-1190
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC1352168
- OpenAlex
- W1969464492
- Cited by
- 1,308
- References
- 28
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 26 · 2023: 51 · 2022: 57 · 2021: 60 · 2020: 72 · 2019: 62 · 2018: 62 · 2017: 64 · 2016: 63 · 2015: 71 · 2014: 85 · 2013: 74 · 2012: 68
- FWCI
- 28.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Prostate Cancer Foundation
- National Institutes of Health
- National Cancer Institute (R01CA093678)
- National Institute of Allergy and Infectious Diseases (R01AI039642)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- NKG2D, NKG2D ligands, DNA damage response, innate immunity, ATM kinase, ATR kinase, Chk1, genotoxic stress, natural killer cells, CD8+ T cells, cancer cell lines, siRNA
- MeSH terms
- Checkpoint Kinase 1, Animals, Cell Transformation, Neoplastic, DNA Damage, DNA Replication, Fibroblasts, Humans, Immune System, Immunity, Innate, Kinetics, Ligands, Mice, Inbred C57BL, Phosphorylation, Protein Kinases, Receptors, Immunologic, Up-Regulation, Aphidicolin, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cell Line, Tumor, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.